Beijing, China

Kemei Wu


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kemei Wu: Innovator in Pharmaceutical Chemistry

Introduction

Kemei Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research on optically active clausenamides. His work focuses on the medical applications of these compounds, which have potential benefits in treating various neurodegenerative diseases.

Latest Patents

Kemei Wu holds a patent for "Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use." This invention relates to new optically active clausenamide derivatives and their preparation processes. The pharmaceutical compositions derived from these compounds are particularly useful in addressing conditions such as hypoxia protection, nootropic effects, and neurodegenerative diseases like cerebral ischemia, Alzheimer's disease, and vascular dementia. He has 1 patent to his name.

Career Highlights

Kemei Wu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development. His work has garnered attention for its potential impact on medical science and therapeutic applications. His dedication to advancing pharmaceutical chemistry is evident in his innovative approaches to drug development.

Collaborations

Kemei Wu collaborates with notable colleagues, including Juntian Zhang and Liang Huang. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Kemei Wu is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for neurodegenerative diseases. His contributions through innovative patents and collaborations highlight the importance of research in improving medical outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…